These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1651161)

  • 1. Lipoprotein metabolism and atherogenesis: implications for therapy.
    Kostner GM
    Cardiology; 1991; 78(3):194-201. PubMed ID: 1651161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hyperlipoproteinemias.
    Patsch W; Patsch JR; Gotto AM
    Med Clin North Am; 1989 Jul; 73(4):859-93. PubMed ID: 2657266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiology and pathophysiology of the metabolism of lipoproteins].
    Sandhofer F
    Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolism and possible mechanisms of atherogenesis induced by lipoprotein (a)].
    Krempler F
    Wien Klin Wochenschr Suppl; 1984; 151():1-12. PubMed ID: 6091345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lp(a): a link between thrombosis and atherosclerosis.
    Scanu AM
    Eur J Epidemiol; 1992 May; 8 Suppl 1():76-8. PubMed ID: 1387094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current standards in diagnosis and therapy of hyperlipoproteinemia.
    Fischer S; Schatz U; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):15-8. PubMed ID: 23357135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a)-clinical aspects and future challenges.
    Kurt B; Soufi M; Sattler A; Schaefer JR
    Clin Res Cardiol Suppl; 2015 Apr; 10(Suppl 1):26-32. PubMed ID: 25732622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
    Solfrizzi V; Capurso C; Colacicco AM; D'Introno A; Fontana C; Capurso SA; Torres F; Gadaleta AM; Koverech A; Capurso A; Panza F
    Atherosclerosis; 2006 Oct; 188(2):455-61. PubMed ID: 16384561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary hyperlipoproteinemia].
    Yamamura T
    Nihon Rinsho; 1993 Aug; 51(8):2182-9. PubMed ID: 8411690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent pathophysiologic aspects of atherogenesis].
    Kostner G
    Wien Med Wochenschr; 1990 Feb; 140(4):101-9. PubMed ID: 2158191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipoproteinemias in atherosclerosis, thrombosis and restenosis after coronary angioplasty.
    Myler RK; Ryan C; Dunlap R; Shaw RE; Bashour TT; Cumberland DC; Mooney MR
    J Invasive Cardiol; 1995 Mar; 7(2):33-46. PubMed ID: 10155712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein Lp(a): impact on atherosclerosis and immunochemical quantification.
    Kostner GM
    Przegl Lek; 1989; 46(7):560-2. PubMed ID: 2531445
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study.
    Leebmann J; Roeseler E; Julius U; Heigl F; Spitthoever R; Heutling D; Breitenberger P; Maerz W; Lehmacher W; Heibges A; Klingel R;
    Circulation; 2013 Dec; 128(24):2567-76. PubMed ID: 24056686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [LP (a) lipoprotein: a new independent risk factor for atherogenesis].
    Davidoff P
    Rev Med Chil; 1991 Jan; 119(1):64-8. PubMed ID: 1840458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of lipoprotein receptors in lipid transport and in the pathogenesis of the hyperlipoproteinemias.
    Chait A
    Spec Top Endocrinol Metab; 1983; 5():1-53. PubMed ID: 6322371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nicotinic acid and derivatives for therapy of hyperlipoproteinemia].
    Ishikawa T
    Nihon Rinsho; 1994 Dec; 52(12):3292-7. PubMed ID: 7853725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia].
    Gajdos M; Fedelesova V; Mongiellova V; Cibulova L; Huttova D; Polak F; Krivosikova Z
    Bratisl Lek Listy; 1999 Aug; 100(8):449-53. PubMed ID: 10645034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(A): physiologic function, association with atherosclerosis, and effects of lipid-lowering drug therapy.
    Spinler SA; Cziraky MJ
    Ann Pharmacother; 1994 Mar; 28(3):343-51. PubMed ID: 8193425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipoproteins and their metabolism].
    Rywik S; Broda G
    Kardiol Pol; 1992; 36(2):110-4. PubMed ID: 1583826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.